Levetiracetam-induced pancytopenia

Pancytopenia is a rare side effect of levetiracetam (LEV) that is associated with severe morbidity that requires hospitalization. Here, we report a patient with a right temporoparietal tumor who underwent a temporal craniotomy with resection of the mass and was started on LEV for seizure prophylaxis...

Descripción completa

Detalles Bibliográficos
Autores principales: Alzahrani, Talal, Kay, Dana, Alqahtani, Saeed A., Makke, Yamane, Lesky, Linda, Koubeissi, Mohamad Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681875/
https://www.ncbi.nlm.nih.gov/pubmed/26744695
http://dx.doi.org/10.1016/j.ebcr.2015.06.001
_version_ 1782405786147749888
author Alzahrani, Talal
Kay, Dana
Alqahtani, Saeed A.
Makke, Yamane
Lesky, Linda
Koubeissi, Mohamad Z.
author_facet Alzahrani, Talal
Kay, Dana
Alqahtani, Saeed A.
Makke, Yamane
Lesky, Linda
Koubeissi, Mohamad Z.
author_sort Alzahrani, Talal
collection PubMed
description Pancytopenia is a rare side effect of levetiracetam (LEV) that is associated with severe morbidity that requires hospitalization. Here, we report a patient with a right temporoparietal tumor who underwent a temporal craniotomy with resection of the mass and was started on LEV for seizure prophylaxis per the neurosurgery local protocol. The patient developed LEV-induced pancytopenia, which was successfully managed by discontinuation of this medication. Our report aims to increase awareness of this rare cause of pancytopenia among clinicians.
format Online
Article
Text
id pubmed-4681875
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-46818752016-01-07 Levetiracetam-induced pancytopenia Alzahrani, Talal Kay, Dana Alqahtani, Saeed A. Makke, Yamane Lesky, Linda Koubeissi, Mohamad Z. Epilepsy Behav Case Rep Case Report Pancytopenia is a rare side effect of levetiracetam (LEV) that is associated with severe morbidity that requires hospitalization. Here, we report a patient with a right temporoparietal tumor who underwent a temporal craniotomy with resection of the mass and was started on LEV for seizure prophylaxis per the neurosurgery local protocol. The patient developed LEV-induced pancytopenia, which was successfully managed by discontinuation of this medication. Our report aims to increase awareness of this rare cause of pancytopenia among clinicians. Elsevier 2015-07-24 /pmc/articles/PMC4681875/ /pubmed/26744695 http://dx.doi.org/10.1016/j.ebcr.2015.06.001 Text en © 2015 The Authors. Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Alzahrani, Talal
Kay, Dana
Alqahtani, Saeed A.
Makke, Yamane
Lesky, Linda
Koubeissi, Mohamad Z.
Levetiracetam-induced pancytopenia
title Levetiracetam-induced pancytopenia
title_full Levetiracetam-induced pancytopenia
title_fullStr Levetiracetam-induced pancytopenia
title_full_unstemmed Levetiracetam-induced pancytopenia
title_short Levetiracetam-induced pancytopenia
title_sort levetiracetam-induced pancytopenia
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681875/
https://www.ncbi.nlm.nih.gov/pubmed/26744695
http://dx.doi.org/10.1016/j.ebcr.2015.06.001
work_keys_str_mv AT alzahranitalal levetiracetaminducedpancytopenia
AT kaydana levetiracetaminducedpancytopenia
AT alqahtanisaeeda levetiracetaminducedpancytopenia
AT makkeyamane levetiracetaminducedpancytopenia
AT leskylinda levetiracetaminducedpancytopenia
AT koubeissimohamadz levetiracetaminducedpancytopenia

Ejemplares similares